Director, Therapeutic Area Strategy, Immunology

Brings external benchmarking, analysis and insights, and judgment to support the TA Strategy Head in developing Immunology therapeutic area strategy. Brings both understanding of the pharmaceutical industry and the Immunology to derive insightful and differentiating competitive advantages over our peers. Provides key commercial insights to the R&D project teams, particularly for early phase programs. This includes creating product forecasts and assessing competitive landscape and portfolio strategic fit. Analyses reports and publications to extract key messages, including building product forecasts. Supports development and delivery of TA-specific strategic external insights to support identification of growth opportunities, emerging competitive challenges and support creation of a third-party view around key strategic levers, and commissions targeted primary research. Supports strategy and commercial analysis for business development activities. Actively contribute to Global /Unit Strategic Planning process.

The Novartis Strategy & Growth, Therapeutic Area Strategy team for Immunology is seeking a new TA Strategy Director who will support the creation and update of TA strategy; provide early-phase commercial insights to project teams; guide TA-specific internal pipeline development and external licensing / acquisitions opportunities; and support integrated enterprise alignment across Biomedical Research (BR), Development, Strategy & Growth (S&G;), and the Commercial US and International units.

• Bachelor's degree required. Advanced degree (PhD, MD or other advanced University degree) and / or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly preferred.

• In-depth TA knowledge (or track record to acquire required TA expertise effectively and rapidly) in Immunology.

• Highly agile having the capacity to support a number of strategic DAs within a TA and multiple programs internal and external.

• Substantial experience evaluating new product opportunities (through M&A, BD&L and internal research programs).

• At least 5-7 years of Industry pharma and/or medical devices Experience in Research & Development and/or commercial functions with experience conducting, commissioning, analyzing primary research.

• Experience of strategy development and asset shaping early in lifecycle (any functional perspective).

• Recent (post 2015) local US in-market experience; local US experience includes working within the US market with the local US customers, US health care systems / systems.